Navigation Links
Mediatech Moves to Prince William County Innovation Park

MANASSAS, Va., Sept. 27 /PRNewswire/ -- Mediatech, Inc. is settling into their brand new 100,000-ft2 facility constructed on 10 acres of land in Prince William County. Right down the road from George Mason University's National Center for Biodefense, Mediatech joins other biotechnology and technology companies, including ATCC in Innovation Park.

(Photo: )

The brand new manufacturing plant has been a work in progress since 2004 when Mediatech was named VaBio Company of the Year. The state and county announced they would provide cash grants and other incentives for the relocation 17 miles west. Mediatech's new corporate headquarters and manufacturing operations facility integrates state-of-the-art systems and innovative technology.

Emphasis is on the unique filling process, designed by in house personnel, that provides higher sterility assurance levels than all others in the industry. In addition to these vast improvements, the manufacturing plant will also have separate production lines for animal and non-animal products, a major benefit for pharmaceutical customers.

Mediatech, Inc was recently licensed as a drug establishment for the production of Water for Injection (WFI). All products are made using WFI quality water that is tested in accordance with the U.S. Pharmacopeia. The WFI system in place is capable of producing up to 28,000 liters of WFI per day.

Although all contact telephone lines will remain the same, please be advised the new Mediatech, Inc. address is:

9345 Discovery Blvd.

Manassas, VA 20109

About Mediatech, Inc

Mediatech, Inc. is a leading manufacturer and supplier of cell culture and molecular biology reagents to biopharmaceutical, academic and government research facilities, as well as biotechnology companies. In addition to following current Good Manufacturing Processes (cGMP) and complying with FDA Guidelines for Class I Medical Devices, Mediatech is certified under ISO 13485:2003 and compliant with ISO 17025:2001. Mediatech's facility design and Quality Assurance Systems guarantee low endotoxin levels for both liquid and powdered products and meets the most rigid Sterility Assurance Levels for liquid products. All cellgro(R) basal media and salt solutions must test negative for mycoplasma prior to release. For more information visit

Contact: Julie Fry, International Marketing Associate I, Mediatech, Inc. 1.800.CELLGRO or

SOURCE Mediatech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin spaceport committee moves closer to formation
2. Sonic Foundrys Mediasite moves to podcasts
3. Blogging moves to corporate America
4. A budget that moves Wisconsin forward
5. Merge eFilm corporate merger with Canadian firm moves ahead
6. Interview: Dr. William Yasnoff on health records, part 2
7. Interview: Dr. William Yasnoff on patient-centric IT
8. Exclusive WTN Interview with Don Williamson
9. $2 million venture debt fund available for high-growth Dane County businesses
10. Local group building Dane County economic development corp.
11. Oneida County gets GIS link for better navigation
Post Your Comments:
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):